Bausch Health Companies | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
Amgen USD 5.97B 781M 2024-12
ANI Pharmaceuticals USD 110.29M 134.46M 2024-12
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Bausch Health Companies USD 1.81B 130M 2024-09
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 9.13B 94M 2024-12
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 178.93M 745K 2024-12
Danaher USD 3.89B 489M 2024-12
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 11.13B 1.86B 2024-12
Gilead Sciences USD 5.99B 17M 2024-12
Novo Nordisk 60B 2.22B 2024-09
Pacira USD 147.37M 17.66M 2024-12
Perrigo USD 385.9M 18.5M 2024-12
Prestige Brands USD 161.05M 3.67M 2024-12
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Zoetis USD 1.61B 79M 2024-12



Bausch Health Companies Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.